Skip to main content
Erschienen in: Journal of Neuro-Oncology 2/2017

01.07.2017 | Clinical Study

A cross sectional analysis from a single institution’s experience of psychosocial distress and health-related quality of life in the primary brain tumor population

verfasst von: Dina M. Randazzo, Frances McSherry, James E. Herndon II, Mary Lou Affronti, Eric S. Lipp, Charlene Flahiff, Elizabeth Miller, Sarah Woodring, Maria Freeman, Patrick Healy, Janet Minchew, Susan Boulton, Annick Desjardins, Gordana Vlahovic, Henry S. Friedman, Stephen Keir, Katherine B. Peters

Erschienen in: Journal of Neuro-Oncology | Ausgabe 2/2017

Einloggen, um Zugang zu erhalten

Abstract

Primary brain tumor patients experience high levels of distress. The purpose of this cross-sectional, retrospective study is to evaluate the level and different sources of psychosocial distress and how these pertain to health-related quality of life (HRQoL). The Primary and Recurrent Glioma registry at Duke’s The Preston Robert Tisch Brain Tumor Center was queried retrospectively for demographic and clinical information on patients seen between December 2013 and February 2014. Data also included the National Comprehensive Cancer Network’s Distress Thermometer (NCCN-DT), Functional Assessment of Cancer Therapy-Brain Cancer (FACT-Br), and Functional Assessment of Chronic Illness Therapy- Fatigue (FACIT-F). 829 subjects completed questionnaires. 54% were male; 96% completed the NCCN-DT; 33.3% had a DT score ≥4 (moderate/severe distress). Women reported DT ≥ 4 more often than men (38.6 vs 29.0%; p = 0.005). Patients within 1 year of diagnosis reported DT ≥ 4 more often than those 1+ years after diagnosis (38.8 vs 30.9%; p = 0.034). 73.0% reported physical problems; the most frequent being fatigue (43.2%) and memory/concentration (40.9%). 42.0% complained of emotional problems with worry (29.4%) and nervousness (22.4%) being the most common. Patients who reported at least one practical, family, emotional or physical problem had significantly lower HRQoL scores (p < 0.001). Primary brain tumor patients experience memory dysfunction, fatigue, nervousness, worry, and financial concerns, which have a negative effect on the patient’s HRQoL. By identifying and addressing these stressors, it may be possible to improve patient HRQoL.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
3.
Zurück zum Zitat Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, MacRae JH, Martin M, Pelletier G, Robinson J, Simpson JS, Speca M, Tillotson L, Bultz BD (2004) High levels of untreated distress and fatigue in cancer patients. Br J Cancer 90(12):2297–2304. doi:10.1038/sj.bjc.6601887 PubMedPubMedCentral Carlson LE, Angen M, Cullum J, Goodey E, Koopmans J, Lamont L, MacRae JH, Martin M, Pelletier G, Robinson J, Simpson JS, Speca M, Tillotson L, Bultz BD (2004) High levels of untreated distress and fatigue in cancer patients. Br J Cancer 90(12):2297–2304. doi:10.​1038/​sj.​bjc.​6601887 PubMedPubMedCentral
5.
Zurück zum Zitat Watson L, Groff S, Tamagawa R, Looyis J, Farkas S, Schaitel B, DeIure A, Faris P, Bultz BD (2016) Evaluating the impact of provincial implementation of screening for distress on quality of life, symptom reports, and psychosocial well-being in patients with cancer. J Natl Compr Cancer Netw 14(2):164–172CrossRef Watson L, Groff S, Tamagawa R, Looyis J, Farkas S, Schaitel B, DeIure A, Faris P, Bultz BD (2016) Evaluating the impact of provincial implementation of screening for distress on quality of life, symptom reports, and psychosocial well-being in patients with cancer. J Natl Compr Cancer Netw 14(2):164–172CrossRef
6.
Zurück zum Zitat VanHoose L, Black LL, Doty K, Sabata D, Twumasi-Ankrah P, Taylor S, Johnson R (2015) An analysis of the distress thermometer problem list and distress in patients with cancer. Support Care Cancer 23(5):1225–1232. doi:10.1007/s00520-014-2471-1 CrossRefPubMed VanHoose L, Black LL, Doty K, Sabata D, Twumasi-Ankrah P, Taylor S, Johnson R (2015) An analysis of the distress thermometer problem list and distress in patients with cancer. Support Care Cancer 23(5):1225–1232. doi:10.​1007/​s00520-014-2471-1 CrossRefPubMed
7.
Zurück zum Zitat Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE (2003) Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 9(7):967–982. doi:10.1017/s1355617703970019 CrossRefPubMed Anderson-Hanley C, Sherman ML, Riggs R, Agocha VB, Compas BE (2003) Neuropsychological effects of treatments for adults with cancer: a meta-analysis and review of the literature. J Int Neuropsychol Soc 9(7):967–982. doi:10.​1017/​s135561770397001​9 CrossRefPubMed
9.
Zurück zum Zitat Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10(1):19–28CrossRefPubMed Zabora J, BrintzenhofeSzoc K, Curbow B, Hooker C, Piantadosi S (2001) The prevalence of psychological distress by cancer site. Psychooncology 10(1):19–28CrossRefPubMed
10.
Zurück zum Zitat Keir ST, Calhoun-Eagan RD, Swartz JJ, Saleh OA, Friedman HS (2008) Screening for distress in patients with brain cancer using the NCCN’s rapid screening measure. Psychooncology 17(6):621–625. doi:10.1002/pon.1271 CrossRefPubMed Keir ST, Calhoun-Eagan RD, Swartz JJ, Saleh OA, Friedman HS (2008) Screening for distress in patients with brain cancer using the NCCN’s rapid screening measure. Psychooncology 17(6):621–625. doi:10.​1002/​pon.​1271 CrossRefPubMed
11.
Zurück zum Zitat Jacobsen PB, Donovan KA, Trask PC, Fleishman SB, Zabora J, Baker F, Holland JC (2005) Screening for psychologic distress in ambulatory cancer patients. Cancer 103(7):1494–1502. doi:10.1002/cncr.20940 CrossRefPubMed Jacobsen PB, Donovan KA, Trask PC, Fleishman SB, Zabora J, Baker F, Holland JC (2005) Screening for psychologic distress in ambulatory cancer patients. Cancer 103(7):1494–1502. doi:10.​1002/​cncr.​20940 CrossRefPubMed
14.
Zurück zum Zitat Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC (1998) Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 82(10):1904–1908CrossRefPubMed Roth AJ, Kornblith AB, Batel-Copel L, Peabody E, Scher HI, Holland JC (1998) Rapid screening for psychologic distress in men with prostate carcinoma: a pilot study. Cancer 82(10):1904–1908CrossRefPubMed
16.
Zurück zum Zitat Goebel S, von Harscher M, Mehdorn HM (2011) Comorbid mental disorders and psychosocial distress in patients with brain tumours and their spouses in the early treatment phase. Support Care Cancer 19(11):1797–1805. doi:10.1007/s00520-010-1021-8 CrossRefPubMed Goebel S, von Harscher M, Mehdorn HM (2011) Comorbid mental disorders and psychosocial distress in patients with brain tumours and their spouses in the early treatment phase. Support Care Cancer 19(11):1797–1805. doi:10.​1007/​s00520-010-1021-8 CrossRefPubMed
17.
Zurück zum Zitat Lambert SD, Pallant JF, Clover K, Britton B, King MT, Carter G (2014) Using Rasch analysis to examine the distress thermometer’s cut-off scores among a mixed group of patients with cancer. Qual Life Res 23(8):2257–2265. doi:10.1007/s11136-014-0673-0 CrossRefPubMed Lambert SD, Pallant JF, Clover K, Britton B, King MT, Carter G (2014) Using Rasch analysis to examine the distress thermometer’s cut-off scores among a mixed group of patients with cancer. Qual Life Res 23(8):2257–2265. doi:10.​1007/​s11136-014-0673-0 CrossRefPubMed
18.
Zurück zum Zitat Antoniadis D, Lavrentiadis G, Papadopoulos VN, Ierodiakonou I, Garyfallos G (2015) The validity of the distress thermometer in Greek colon cancer patients. Acta Chir Belg 115(6):387–392CrossRefPubMed Antoniadis D, Lavrentiadis G, Papadopoulos VN, Ierodiakonou I, Garyfallos G (2015) The validity of the distress thermometer in Greek colon cancer patients. Acta Chir Belg 115(6):387–392CrossRefPubMed
19.
Zurück zum Zitat Gunnarsdottir S, Thorvaldsdottir GH, Fridriksdottir N, Bjarnason B, Sigurdsson F, Skulason B, Smari J (2012) The psychometric properties of the Icelandic version of the distress thermometer and problem list. Psychooncology 21(7):730–736. doi:10.1002/pon.1950 CrossRefPubMed Gunnarsdottir S, Thorvaldsdottir GH, Fridriksdottir N, Bjarnason B, Sigurdsson F, Skulason B, Smari J (2012) The psychometric properties of the Icelandic version of the distress thermometer and problem list. Psychooncology 21(7):730–736. doi:10.​1002/​pon.​1950 CrossRefPubMed
20.
Zurück zum Zitat Lazenby M, Dixon J, Bai M, McCorkle R (2014) Comparing the distress thermometer (DT) with the patient health questionnaire (PHQ)-2 for screening for possible cases of depression among patients newly diagnosed with advanced cancer. Palliat Support Care 12(1):63–68. doi:10.1017/s1478951513000394 CrossRefPubMed Lazenby M, Dixon J, Bai M, McCorkle R (2014) Comparing the distress thermometer (DT) with the patient health questionnaire (PHQ)-2 for screening for possible cases of depression among patients newly diagnosed with advanced cancer. Palliat Support Care 12(1):63–68. doi:10.​1017/​s147895151300039​4 CrossRefPubMed
24.
Zurück zum Zitat Osoba D, Brada M, Prados MD, Yung WK (2000) Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-oncol 2(4):221–228PubMedPubMedCentral Osoba D, Brada M, Prados MD, Yung WK (2000) Effect of disease burden on health-related quality of life in patients with malignant gliomas. Neuro-oncol 2(4):221–228PubMedPubMedCentral
Metadaten
Titel
A cross sectional analysis from a single institution’s experience of psychosocial distress and health-related quality of life in the primary brain tumor population
verfasst von
Dina M. Randazzo
Frances McSherry
James E. Herndon II
Mary Lou Affronti
Eric S. Lipp
Charlene Flahiff
Elizabeth Miller
Sarah Woodring
Maria Freeman
Patrick Healy
Janet Minchew
Susan Boulton
Annick Desjardins
Gordana Vlahovic
Henry S. Friedman
Stephen Keir
Katherine B. Peters
Publikationsdatum
01.07.2017
Verlag
Springer US
Erschienen in
Journal of Neuro-Oncology / Ausgabe 2/2017
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI
https://doi.org/10.1007/s11060-017-2535-4

Weitere Artikel der Ausgabe 2/2017

Journal of Neuro-Oncology 2/2017 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.